4//SEC Filing
Humes Jennifer 4
Accession 0001140361-25-010119
CIK 0001635088other
Filed
Mar 23, 8:00 PM ET
Accepted
Mar 24, 9:01 PM ET
Size
7.2 KB
Accession
0001140361-25-010119
Insider Transaction Report
Form 4
Humes Jennifer
Chief Accounting Officer
Transactions
- Award
Stock Option (Right to Buy)
2025-03-20+115,108→ 115,108 totalExercise: $10.97Exp: 2035-03-19→ Common Shares (115,108 underlying) - Award
Common Shares
2025-03-20+112,255→ 112,255 total
Footnotes (2)
- [F1]Award of restricted stock units with respect to Common Shares ("RSUs") with a vesting commencement date of March 20, 2025. These RSUs vest (i) 25% on the first anniversary of the vesting commencement date and (ii) in twelve (12) successive equal quarterly installments thereafter, subject to the reporting person's Continuous Service through each applicable vesting date.
- [F2]Award of stock options to purchase Common Shares with a vesting commencement date of February 20, 2025. These options vest and become exercisable (i) 25% on the first anniversary of the vesting commencement date and (ii) in thirty-six (36) successive equal monthly installments thereafter, subject to the reporting person's Continuous Service through each applicable vesting date.
Documents
Issuer
Roivant Sciences Ltd.
CIK 0001635088
Entity typeother
Related Parties
1- filerCIK 0002058012
Filing Metadata
- Form type
- 4
- Filed
- Mar 23, 8:00 PM ET
- Accepted
- Mar 24, 9:01 PM ET
- Size
- 7.2 KB